|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.87 EUR | +0.20% |
|
+3.74% | +10.08% |
| 14/04 | ImmuCell Corporation Announces Board Changes | CI |
| 14/04 | Lineage Cell Therapeutics, Inc. Announces Formation of Scientific Advisory Board and Executive Appointment | CI |
| Capitalization | 40.07B 46.91B 36.95B 34.87B 64.8B 4,392B 66.44B 433B 170B 2,098B 176B 172B 7,493B | P/E ratio 2026 * |
20.3x | P/E ratio 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise value | 72.31B 84.64B 66.67B 62.92B 117B 7,925B 120B 781B 307B 3,785B 318B 311B 13,520B | EV / Sales 2026 * |
1.59x | EV / Sales 2027 * | 1.49x |
| Free-Float |
100% | Yield 2026 * |
0.54% | Yield 2027 * | 1.88% |
Last Transcript: Bayer AG
| 1 day | +0.04% | ||
| 1 week | +4.10% | ||
| Current month | +3.80% | ||
| 1 month | +1.97% | ||
| 3 months | -1.90% | ||
| 6 months | +49.58% | ||
| Current year | +10.46% |
| 1 week | 39.6 |  | 41.21 |
| 1 month | 36.88 | | 41.21 |
| Current year | 35.2 | | 49.78 |
| 1 year | 20.52 | | 49.78 |
| 3 years | 18.38 | | 61.91 |
| 5 years | 18.38 | | 67.99 |
| 10 years | 18.38 | | 123.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 59 | 01/06/2023 |
| Director of Finance/CFO | 56 | 01/06/2018 | |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Achleitner
BRD | Director/Board Member | 69 | 01/04/2002 |
André van Broich
BRD | Director/Board Member | 55 | 01/04/2012 |
| Director/Board Member | 66 | 01/04/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 4.28% | 962 M€ | |
| -10.57% | 4.1% | 1 M€ | |
| 0.00% | 4.1% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.04% | +4.10% | +95.69% | -33.38% | 46.91B | |
| -1.06% | +0.27% | +26.92% | +147.78% | 832B | |
| -0.21% | -1.25% | +56.83% | +43.25% | 573B | |
| -0.71% | -0.11% | +17.95% | +26.91% | 365B | |
| +0.27% | -0.75% | +29.45% | +14.12% | 322B | |
| -0.37% | -0.04% | +44.88% | +25.73% | 313B | |
| -1.05% | -0.58% | +51.74% | +3.95% | 297B | |
| -0.71% | +0.25% | +35.34% | +37.34% | 292B | |
| -0.34% | +2.12% | +22.32% | +39.13% | 189B | |
| +0.03% | -0.78% | +34.16% | +66.96% | 173B | |
| Average | -0.12% | -0.30% | +41.53% | +37.18% | 340.18B | |
| Weighted average by Cap. | -0.08% | -0.61% | +36.84% | +58.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.38B 53.12B 41.84B 39.49B 73.38B 4,974B 75.24B 490B 193B 2,375B 199B 195B 8,485B | 46.63B 54.58B 43B 40.58B 75.4B 5,111B 77.31B 504B 198B 2,441B 205B 201B 8,719B |
| Net income | 1.93B 2.25B 1.78B 1.68B 3.11B 211B 3.19B 20.8B 8.18B 101B 8.46B 8.28B 360B | 3.03B 3.54B 2.79B 2.63B 4.9B 332B 5.02B 32.7B 12.86B 158B 13.3B 13.02B 566B |
| Net Debt | 32.23B 37.73B 29.72B 28.05B 52.12B 3,533B 53.44B 348B 137B 1,687B 142B 139B 6,027B | 29.32B 34.32B 27.04B 25.51B 47.41B 3,214B 48.62B 317B 124B 1,535B 129B 126B 5,483B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/04/26 | 40.74 € | -0.12% | 440,099 |
| 13/04/26 | 40.79 € | +1.67% | 1,688,782 |
| 10/04/26 | 40.12 € | -0.82% | 2,159,682 |
| 09/04/26 | 40.45 € | -0.07% | 1,855,752 |
| 08/04/26 | 40.48 € | +3.08% | 2,821,861 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BAYN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition